CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1,714 enrolled
Drug / intervention
Salbutamol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00861926
NCT00861926Phase 3Completed

48-week, Multicentre, Multinational, Randomized, Double-blind, 2-arm Parallel Group, Comparing the Efficacy of FOSTER for Maintenance & Reliever Versus Fixed-dose FOSTER for Maintenance + Salbutamol as Reliever in Asthmatics ≥ 18 Years of Age

Chiesi Farmaceutici S.p.A.·interventional·Posted Mar 16, 2009·Updated May 7, 2026

In Brief

A Phase 3 clinical trial evaluating Salbutamol and Beclomethasone dipropionate + Formoterol for Asthma. Completed, enrolled 1,714 participants across 206 sites in 14 countries.

Detailed Summary

Primary objective: The primary objective of the study was to compare the efficacy of Maintenance and Reliever Therapy (MART) with Foster® 100/6 μg (one inhalation bid) plus additional inhalations as needed, with the standard treatment of Foster® 100/6 μg (one inhalation bid) plus salbutamol 100 μg (Ventolin ®) additional inhalations as needed in not fully controlled asthmatic patients. Secondary objectives: The secondary objectives of the study were: * to evaluate the effect of treatments on lung function parameters and on other clinical outcome measures, and * to assess the safety and the tolerability of Foster® as MART.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesBulgaria, Croatia, Czechia, France, Germany, Italy, Poland, Romania, Russia, Serbia, Spain, Turkey (Türkiye), Ukraine, United Kingdom
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 16, 2009
Enrollment StartMar 20, 2009
Primary CompletionDec 7, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.3 years ago

Interventions

Salbutamoldrug

Administered via a pressurized metered-dose inhaler

Beclomethasone dipropionate + Formoteroldrug

Administered via a pressurized metered-dose inhaler